Kratom detox · Tarzana, CA

Kratom detox in Los Angeles, with the evidence in proportion.

Kratom detox in Los Angeles starts with an accurate picture: NIDA reports that people who stop regular kratom use may have mild to moderate withdrawal, while the FDA warns of seizures, liver injury and addiction and calls concentrated 7-OH a potent opioid. No medicine is approved for kratom withdrawal. At Lumora in Tarzana, an assessment decides where withdrawal should begin.

Call (818) 422-7772 Check insurance by phone

Kratom detox in Los Angeles: what does withdrawal involve?

Kratom withdrawal is the body’s reaction when regular use stops, and NIDA reports that people who have it tend to have mild to moderate symptoms. Only a minority of people who use kratom report withdrawal, and a smaller minority report symptoms of a substance use disorder. NIDA adds that kratom withdrawal has not been well studied.

Neither agency publishes a symptom list for withdrawal from plain kratom leaf. The FDA does list what people have reported after concentrated 7-OH products: restlessness, body aches, fatigue, irritability and cold sweats. Kratom detox is the supervised start of stopping, the first stage of care rather than all of it.

Last updated October 10, 2026

The plant and its compounds

Is kratom an opioid, and can it be addictive?

Kratom is not a classic opioid, but its compounds act on the same mu-opioid receptors. Kratom is a tropical tree, Mitragyna speciosa, native to Southeast Asia, and the name also covers products made from its leaves.

NIDA says people take kratom as capsules, as powder mixed into food or drink, as tea or as liquid extracts. The FDA cites national survey data showing about 1.7 million Americans aged 12 and older used it in 2021. People report using it to self-treat pain, cough, diarrhea, anxiety, depression and opioid withdrawal.

How it acts in the body

Its main compounds are mitragynine and 7-hydroxymitragynine (7-OH), and the body converts some mitragynine into 7-OH. Both activate mu-opioid receptors, yet NIDA says the effects only partly resemble opioids: kratom leaf and mitragynine do not appear to slow breathing the way opioids do, while 7-OH can in laboratory models, an effect naloxone reversed. The FDA says 7-OH is far more potent at that receptor than mitragynine or morphine.

Users describe stimulant-like effects at small amounts and sedative or opioid-like effects at larger ones, though NIDA notes studies have not established this. For withdrawal from opioid medicines themselves, and the treatments approved for it, see opioid withdrawal and how it is treated.

Kratom addiction

The FDA lists substance use disorder among kratom’s serious adverse events, recognized by signs such as cravings, tolerance and withdrawal. NIDA reports it in a smaller minority of users and points out that the DSM-5 has no separate kratom diagnosis.

Know the product

7-OH vs kratom: why does the product matter for withdrawal?

Concentrated 7-OH products are a different risk from traditional kratom leaf. The FDA calls 7-OH a potent opioid and an emerging public health threat, and says some 7-OH products are not accurately labeled and are sometimes marketed as kratom.

Kratom leaf or concentrated 7-OH?
Question	Traditional kratom leaf products	Concentrated 7-OH products
What it is	Leaf from the kratom tree, dried, powdered or extracted	Products in which 7-OH has been concentrated, added or enhanced, including synthetic versions
How much 7-OH	Under 2% of the leaf’s alkaloids, a trace amount	Far above natural levels; the FDA says some “spiked” or “enhanced” leaf holds 7-OH at 500% above them
Strength	Effects only partly opioid-like, according to NIDA	One study cited by the FDA found 7-OH 13 times more potent than morphine
Common forms	Capsules, powder, tea, liquid extracts	Tablets, gummies, candies, drink mixes and shots
Where it is sold	Online and in stores	Gas stations, corner stores, smoke and vape shops, and online
Names on the label	Usually sold simply as kratom	7-OH, 7-hydroxymitragynine, 7-OHMG, 7-Hydroxy, 7-HMG or just “7”
Withdrawal reported	Mild to moderate in NIDA’s summary; no federal symptom list	Restlessness, body aches, fatigue, irritability and cold sweats, in reports to the FDA
Federal position	Not approved for any medical use and not lawful as a supplement; not federally scheduled, per NIDA	FDA warning letters, product seizures and a DEA notice of intent to temporarily schedule (July 2026); three related synthetic compounds placed in Schedule I in August 2026

From FDA pages, press releases and a letter to clinicians dated July 2025 to July 2026, and NIDA’s March 2026 kratom summary. The FDA says its scheduling recommendation targets concentrated and synthetic 7-OH, not natural leaf with trace amounts.

This is why the first question on the call is which product, not simply “kratom.” Someone using concentrated 7-OH shots is using what the FDA calls a potent opioid, a different situation from someone drinking leaf tea, and the assessment weighs that difference. If you find packaging, read the label for the names in the table and bring it up on the call.

Severity

Kratom withdrawal symptoms: how serious, by the federal evidence?

The federal evidence points to withdrawal that is usually mild to moderate, alongside rarer harms that deserve attention. The two agencies emphasize different things, and both matter to a family.

What NIDA’s research finds

People may have mild to moderate withdrawal when regular use stops, and only a minority report it. The more common effects of using kratom are mild: nausea, constipation, dizziness and drowsiness. NIDA is clear that withdrawal has not been well studied, so the absence of a symptom list reflects a gap in research, not proof that nothing happens.

What the FDA has seen

The FDA lists liver toxicity, seizures and substance use disorder as serious adverse events, and names sedation, nausea and vomiting, constipation, physical dependence, withdrawal and slowed breathing that may lead to death among kratom’s effects. In its 2025 letter to clinicians, the FDA said it was seeing rising adverse event and poison control reports linked to 7-OH.

How many deaths are linked to kratom?

NIDA cites a 2019 report of 11 deaths in the United States between 2011 and 2017 associated with kratom, two of them with kratom alone. Nearly all fatal cases involved other drugs or contaminants, and the FDA likewise describes deaths as rare and usually involving other substances.

When does supervision make sense?

Mild on average does not mean mild for everyone. The situations that raise the stakes are concentrated 7-OH use, other substances taken at the same time, and mental health symptoms that kratom was being used to manage. Those are the questions the assessment asks first.

Treatment

Kratom withdrawal treatment: is there an approved medicine?

No. NIDA says there are no FDA-approved medications or therapies for kratom withdrawal or for kratom-related substance use disorder. The approaches studied so far come from limited case reports and animal research.

Two points follow for families. An article that presents one prescription as the standard treatment for kratom withdrawal is going further than the federal research does. And whether any medicine is used, and which, is decided by the clinician who has assessed the person, weighing the product, the amount and everything else involved.

The FDA notes that approved treatments do exist for problems many people use kratom to manage: opioid addiction, anxiety, mood disorders and pain. Mental health conditions that occur with substance use are part of the assessment; learn how dual diagnosis care works at Lumora.

Other risks

What other health risks does kratom carry?

Beyond withdrawal, the FDA and NIDA point to liver injury, seizures, contamination and the danger of combining kratom with other drugs. Most serious reports are rare, but they are the reason kratom is not treated as harmless.

Liver and nervous system

The FDA lists liver toxicity among serious adverse events. NIDA describes liver problems as rare, seen mostly in a small minority with long-term heavy use, and lists other rare serious reports: confusion, tremor, seizures, high blood pressure and slowed breathing.

Contamination

Kratom products contaminated with Salmonella and heavy metals have made people ill, according to the FDA, and NIDA notes the same contaminants. What is printed on a package may not match what is inside it.

Not a medicine

The FDA has approved no medical use for kratom, warns against using it to treat any condition, and says no kratom drug product is legally marketed. It also notes that no well-designed human study of kratom’s abuse potential has been completed; it funded one in September 2024.

Combined with other drugs

Because nearly all kratom deaths in NIDA’s summary involved other substances, everything a person takes matters at assessment. When pain pills, sedatives or stimulants are also in the picture, our page on detox from misused prescription medicines explains each class.

Pregnancy

Can kratom use in pregnancy affect a newborn?

Yes. The FDA reports neonatal abstinence syndrome, withdrawal in the newborn, after prolonged kratom exposure before birth, with signs such as jitteriness, irritability and muscle stiffness. NIDA also cites case reports of the syndrome in babies whose mothers used kratom regularly.

Neither agency gives guidance on how kratom should be stopped during pregnancy, so this is a conversation for the prenatal care provider as well as for admissions. Mention a pregnancy at the start of the call; it is one of the facts that shapes where withdrawal should begin.

Federal status

Is kratom legal, and what federal actions has 7-OH faced?

Natural kratom is not federally scheduled, according to NIDA, but federal agencies have acted against concentrated 7-OH since July 2025. The table lists federal actions reported by the FDA through July 13, 2026, and the DEA order published in the Federal Register on August 26, 2026. It covers federal status only; state and local rules are not addressed here.

Federal actions on kratom and 7-OH, July 2025 to August 2026
Date	What happened	What it means
Standing position	FDA: no kratom drug product is legally marketed, no medical use is approved, and kratom is not lawful as a dietary supplement or food additive. NIDA: not federally scheduled; the DEA lists it as a drug of concern.	Kratom on a shop shelf has not been reviewed or approved as a medicine.
July 15, 2025	The FDA sends warning letters to seven firms marketing 7-OH products, some with unproven claims for pain and anxiety.	The first targeted federal step against concentrated 7-OH.
July 29, 2025	The FDA recommends scheduling specific 7-OH products under the Controlled Substances Act, issues a consumer warning and writes to health care professionals.	The scheduling decision itself rests with the DEA, after rulemaking.
December 2, 2025	The FDA seizes about 73,000 units of concentrated 7-OH products, worth about $1 million, from three Missouri firms.	The FDA states concentrated 7-OH cannot lawfully be added to supplements or foods.
July 1, 2026	The DEA announces a notice of intent to temporarily schedule 7-OH above a set threshold, as the FDA reported on July 13, 2026.	It targets concentrated and synthetic 7-OH, not natural leaf.
August 26, 2026	A DEA temporary order, published in the Federal Register, places three synthetic compounds related to 7-OH (mitragynine pseudoindoxyl, MGM-15 and MGM-16) in Schedule I, effective that day until August 26, 2028.	Schedule I is the strictest federal category. The order names these three compounds; it does not schedule natural kratom leaf.

Federal actions reported by the FDA through July 13, 2026, with NIDA’s kratom summary, and the DEA temporary order at 91 FR 54948 (August 26, 2026); all checked October 10, 2026. Federal scheduling can change, so check the Federal Register for any later action.

At Lumora

Kratom detox in Tarzana: where does withdrawal begin?

The assessment decides whether withdrawal can begin at Lumora or needs a hospital first. It asks whether the product is leaf or concentrated 7-OH, how much is used and how often, what else is taken, whether there is a pregnancy, a liver problem or a past seizure, and how mood and sleep have been.

Lumora’s license comes from the California Department of Health Care Services: a residential program with detoxification for six residents, DHCS License No. 191642AP, approved for incidental medical services. Read the state’s listing for Lumora.

Withdrawal is where care starts, not where it ends; if residential treatment is the next step, it takes place in this house, with no move elsewhere. The next stage is set out on our page about residential care after the medical phase, and the detox hub, covering every substance explains the medical phase in general.

We work with many PPO plans. For how plans handle this kind of care, read how insurance treats addiction care; admissions can check your benefits by phone.

Safety first

No response, a seizure or slow breathing after kratom or 7-OH: call 911.

The FDA’s advice for a reaction to a 7-OH product is to call Poison Help at 1-800-222-1222, and to call 911 if the person is unresponsive or the reaction is life threatening. Call 911 as well for a seizure or breathing that has slowed or stopped. For a mental health or substance use crisis, or thoughts of suicide, call or text 988 to reach the Suicide and Crisis Lifeline.

Call 911 Call or text 988

FAQ

Questions families ask

Is kratom withdrawal dangerous?

NIDA describes it as mild to moderate in the people who have it, and says only a minority of kratom users report withdrawal at all. The FDA still lists seizures, liver toxicity and addiction among kratom’s serious harms. Concentrated 7-OH products, or other drugs used alongside kratom, change the picture most.

How long does kratom withdrawal last?

Neither the FDA nor NIDA gives a timeline. NIDA notes that kratom withdrawal has not been well studied, so the day counts printed on many websites do not come from a federal source. How it unfolds for one person is something to watch with a clinician, not predict.

Can you get addicted to kratom?

Some people do. The FDA lists substance use disorder among kratom’s serious adverse events, marked by signs such as cravings, tolerance and withdrawal. NIDA says a smaller minority of users report substance use disorder symptoms, and notes that kratom addiction is not a separate diagnosis in the DSM-5.

What is 7-OH, and how is it different from kratom?

7-hydroxymitragynine is one of kratom’s compounds, under 2% of the alkaloids in natural leaf. The FDA warns about products in which 7-OH is concentrated, added or enhanced, sold as tablets, gummies, drink mixes and shots, and calls it an opioid that can be more potent than morphine.

Is there a medication approved for kratom withdrawal?

No. NIDA says there are no FDA-approved medicines or therapies for kratom withdrawal or kratom-related substance use disorder. What has been tried comes from case reports and animal studies. Any decision about medicine belongs to the clinician who assesses the person.

Is kratom a controlled substance under federal law?

Natural kratom is not federally scheduled, according to NIDA, though the DEA lists it as a drug of concern and the FDA says it is not lawful as a dietary supplement. Concentrated 7-OH is treated differently: the FDA reported a DEA notice of intent, dated July 1, 2026, to temporarily schedule it. On August 26, 2026 a DEA temporary order in the Federal Register placed three related synthetic compounds (mitragynine pseudoindoxyl, MGM-15 and MGM-16) in Schedule I until August 26, 2028. Federal scheduling can change, so check the Federal Register for any later action.

Can kratom be used to get off opioids?

The FDA warns against using kratom to treat any medical condition, opioid withdrawal and opioid use disorder included, and has approved no medical use for it. The FDA also points out that approved treatments for opioid addiction exist. A clinician, not a shop shelf, is the place to start.

Is kratom safe during pregnancy?

The FDA and NIDA both report newborns with neonatal abstinence syndrome after regular kratom use in pregnancy. The FDA lists jitteriness, irritability and muscle stiffness in affected babies. Anyone pregnant who uses kratom should tell their prenatal care provider, and mention the pregnancy on the first call to admissions.

Can kratom damage the liver?

It can. The FDA lists liver toxicity among the serious adverse events reported with kratom. NIDA describes liver problems as rare, seen mostly with long-term heavy use in a small minority of people. A known liver condition is worth mentioning at assessment.

Is it better to wean off kratom or quit all at once?

Neither the FDA nor NIDA sets out a method for stopping, and a website cannot weigh the product, the amount and what else is used. Make that decision with a clinician who has assessed the person, particularly when 7-OH products or other drugs are involved.

Other ways we help

Care at Lumora

Sources

This page is for information and is not a substitute for medical, legal or insurance advice. Sources checked October 10, 2026.

Admissions, 24 hours a day

Kratom detox in Los Angeles, planned around the product actually used.

Call any time and tell us what is being taken, leaf or 7-OH, and what else is in the picture. We will explain whether withdrawal can begin at Lumora or should start in a hospital.